LITELABRequest a Sample
PRODUCT / IGF-1

Full-length SIL recombinant IGF-1.

A protein-level internal standard for quantitative IGF-1 LC-MS/MS assay development.

THE MATERIAL

A standard at the protein level.

Full-length SIL IGF-1 is intended as a mass-distinguishable comparator for IGF-1 method development. Analytical suitability depends on the material and method.

PROTEIN-LEVEL PAIRSCHEMATIC · NOT STRUCTURAL DATA
Endogenous IGF-1LIGHT
Full-length SIL IGF-1HEAVY
A protein-level comparator designed for mass-distinguishable measurement. Behavior in the intended matrix and method requires evaluation.
ILLUSTRATIVE USE

Introduce it before the steps you want to assess.

In a bottom-up assay, adding the full-length standard before relevant preparation and digestion allows it to experience those analytical steps alongside the endogenous target.

  1. 01
    SampleDefine matrix and target
  2. 02
    Add full-length SIL proteinBefore relevant processing
  3. 03
    Process / extractMethod-specific steps
  4. 04
    DigestFor bottom-up methods
  5. 05
    LCSeparate peptides
  6. 06
    MS detectionMeasure light / heavy
  7. 07
    QuantificationApply method calibration

Conceptual sequence, not a validated IGF-1 protocol. It cannot correct changes before addition; behavior must be evaluated in the intended matrix and method.

POINT OF ADDITION

Full-length SIL protein vs heavy peptide.

The comparison describes general methodological scope, not product-specific performance.

01 / EARLIER ENTRY

Full-length SIL protein

  1. Sample
  2. Add SIL protein standard enters
  3. Process / extract
  4. Digest
  5. LC
  6. MS detection
  7. Quantification

Can accompany more of the analytical processing when added before those steps.

02 / LATER ENTRY

Heavy peptide

  1. Sample
  2. Process / extract
  3. Digest
  4. Add heavy peptide standard enters
  5. LC
  6. MS detection
  7. Quantification

Helps normalize downstream measurement; the peptide itself does not undergo protein processing or digestion.

The extent of correction depends on analyte comparability, processing, and assay design. Neither standard automatically addresses every source of variation.

TECHNICAL EVALUATION

Review the material and the method together.

  • Construct and protein form
  • Identity, isotope labeling, and purity characterization
  • Concentration assignment and handling
  • Matrix, point of addition, and method-specific performance

Material characterization and assay validation are distinct. Request the documentation needed for your evaluation.

EVALUATION

Bring your assay context.

Share the matrix, preparation route, analytical format, intended addition point, and documentation needs for a focused technical discussion.

Request an evaluation ↗
NEXT STEP

Request an IGF-1 sample

Share your method and evaluation requirements so the technical discussion can be specific.

Request a Sample